|
INTRAMAR SEAL
|
2.6 g
|
V/MRP/23/0037
|
Bioveta a.s., Čehija
|
QG52X
|
cattle
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/23/0037-01 |
|
24 |
Injektors, 4 g |
-
|
| V/MRP/23/0037-02 |
|
160 |
Injektors, 4 g |
-
|
|
|
Intramar LC
|
-
|
V/NRP/20/0064
|
Bioveta, a.s., Čehija
|
QJ51RV01
|
cattle
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
intramammary suspension
|
| International name (active substance): |
Amoxicillin trihydrate, Potassium clavulanate, Prednisolone
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Bioveta, a.s., Čehija
|
| Date of authorisation/renewal: |
28-Jan-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[DOCX] 26012021LI (26-Jan-2021)
|
| Labelling text: |
[DOCX] 26012021M (26-Jan-2021)
|
| Summary of product characteristics: |
[DOCX] 26012021ZA (26-Jan-2021)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/20/0064-01 |
|
24 |
Injektors, 4 g |
-
|
|
|
INTRAMAR Lacto 200 mg + 50 mg + 10 mg
|
-
|
V/DCP/25/0006
|
Bioveta a.s., Čehija
|
QJ51RV01
|
cattle (lactating cows)
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/25/0006-01 |
|
24 |
Injektors, 4,5 ml |
-
|
| V/DCP/25/0006-02 |
|
24 |
Injektors (un dezinfekcijas salvetes), 4,5 ml |
-
|
|
|
Intramar LC
|
-
|
V/I/24/0067
|
Bioveta, a.s., Čehija
|
QJ51RV01
|
cattle
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
intramammary suspension
|
| International name (active substance): |
Amoxicillin trihydrate, Potassium clavulanate, Prednisolone
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Bioveta, a.s., Čehija
|
| Date of authorisation/renewal: |
16-Oct-2024
|
| Marketing authorisation valid until: |
15-Oct-2029
|
| Marketing authorisation procedure: |
I
|
| Package leaflet: |
[DOCX] 16102024LI (16-Oct-2024)
|
| Labelling text: |
See products section
|
| Summary of product characteristics: |
-
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/I/24/0067-01 |
|
24 |
Injektors, 4 g |
[PDF]
|
|